So-Young International (SY) Competitors $4.32 -0.13 (-2.92%) Closing price 08/1/2025 04:00 PM EasternExtended Trading$4.39 +0.07 (+1.62%) As of 08/1/2025 07:55 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock SY vs. GDRX, DFIN, PLTK, PINC, UPWK, OLO, XMTR, LZ, PHR, and NVEEShould you be buying So-Young International stock or one of its competitors? The main competitors of So-Young International include GoodRx (GDRX), Donnelley Financial Solutions (DFIN), Playtika (PLTK), Premier (PINC), Upwork (UPWK), OLO (OLO), Xometry (XMTR), LegalZoom.com (LZ), Phreesia (PHR), and NV5 Global (NVEE). These companies are all part of the "business services" industry. So-Young International vs. Its Competitors GoodRx Donnelley Financial Solutions Playtika Premier Upwork OLO Xometry LegalZoom.com Phreesia NV5 Global So-Young International (NASDAQ:SY) and GoodRx (NASDAQ:GDRX) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their earnings, valuation, media sentiment, analyst recommendations, profitability, dividends, institutional ownership and risk. Which has more volatility & risk, SY or GDRX? So-Young International has a beta of 1.76, suggesting that its stock price is 76% more volatile than the S&P 500. Comparatively, GoodRx has a beta of 1.24, suggesting that its stock price is 24% more volatile than the S&P 500. Do insiders and institutionals hold more shares of SY or GDRX? 35.3% of So-Young International shares are held by institutional investors. Comparatively, 63.8% of GoodRx shares are held by institutional investors. 16.7% of So-Young International shares are held by insiders. Comparatively, 4.5% of GoodRx shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term. Which has better valuation and earnings, SY or GDRX? GoodRx has higher revenue and earnings than So-Young International. So-Young International is trading at a lower price-to-earnings ratio than GoodRx, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSo-Young International$200.94M2.18-$80.76M-$0.80-5.40GoodRx$792.32M2.04$16.39M$0.0856.63 Do analysts recommend SY or GDRX? So-Young International currently has a consensus price target of $5.50, suggesting a potential upside of 27.31%. GoodRx has a consensus price target of $6.55, suggesting a potential upside of 44.49%. Given GoodRx's higher probable upside, analysts plainly believe GoodRx is more favorable than So-Young International.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score So-Young International 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00GoodRx 0 Sell rating(s) 5 Hold rating(s) 5 Buy rating(s) 1 Strong Buy rating(s) 2.64 Is SY or GDRX more profitable? GoodRx has a net margin of 3.57% compared to So-Young International's net margin of -41.03%. GoodRx's return on equity of 7.85% beat So-Young International's return on equity.Company Net Margins Return on Equity Return on Assets So-Young International-41.03% -2.14% -1.61% GoodRx 3.57%7.85%3.91% Does the media favor SY or GDRX? In the previous week, So-Young International had 2 more articles in the media than GoodRx. MarketBeat recorded 4 mentions for So-Young International and 2 mentions for GoodRx. GoodRx's average media sentiment score of 0.51 beat So-Young International's score of 0.20 indicating that GoodRx is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment So-Young International 1 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral GoodRx 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive SummaryGoodRx beats So-Young International on 12 of the 17 factors compared between the two stocks. Get So-Young International News Delivered to You Automatically Sign up to receive the latest news and ratings for SY and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding SY and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SY vs. The Competition Export to ExcelMetricSo-Young InternationalMedical Services IndustryMedical SectorNASDAQ ExchangeMarket Cap$451.40M$7.18B$5.49B$9.52BDividend YieldN/A2.90%4.73%4.09%P/E Ratio-5.4064.1328.7523.81Price / Sales2.1833.83372.2066.02Price / Cash385.6825.7735.4557.96Price / Book1.648.618.275.55Net Income-$80.76M$239.96M$3.25B$259.20M7 Day Performance-6.90%-5.48%-3.72%-4.64%1 Month Performance29.73%-3.73%4.30%4.41%1 Year Performance-66.55%18.27%25.87%17.95% So-Young International Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SYSo-Young International1.9706 of 5 stars$4.32-2.9%$5.50+27.3%-68.0%$451.40M$200.94M-5.401,800Short Interest ↑GDRXGoodRx3.0441 of 5 stars$5.01+0.2%$6.55+30.6%-48.2%$1.79B$792.32M62.63950Upcoming EarningsDFINDonnelley Financial Solutions2.8054 of 5 stars$65.07+1.1%$71.33+9.6%-20.8%$1.78B$781.90M21.551,800Trending NewsEarnings ReportAnalyst DowngradePLTKPlaytika4.1399 of 5 stars$4.69+0.4%$7.68+63.7%-41.6%$1.75B$2.55B12.343,500News CoverageUpcoming EarningsPINCPremier2.1454 of 5 stars$21.12-0.2%$22.20+5.1%+1.4%$1.74B$1.35B37.052,900Positive NewsUPWKUpwork2.5468 of 5 stars$12.86-1.9%$18.67+45.2%+5.8%$1.73B$769.33M7.70850News CoveragePositive NewsUpcoming EarningsShort Interest ↑OLOOLO1.5447 of 5 stars$10.14flat$10.17+0.3%+92.8%$1.68B$299.11M507.25710Upcoming EarningsXMTRXometry2.2824 of 5 stars$32.84+0.7%$35.78+8.9%+127.8%$1.65B$545.53M-33.171,088News CoveragePositive NewsUpcoming EarningsShort Interest ↑LZLegalZoom.com0.8645 of 5 stars$9.23+1.7%$9.08-1.6%+36.5%$1.65B$681.88M54.291,220News CoveragePositive NewsUpcoming EarningsPHRPhreesia4.2023 of 5 stars$27.11+1.8%$32.27+19.0%+7.0%$1.58B$419.81M-36.632,082Gap DownNVEENV5 Global3.0803 of 5 stars$22.39-2.9%$25.67+14.6%-10.0%$1.55B$941.27M45.235,024News CoverageUpcoming EarningsHigh Trading Volume Related Companies and Tools Related Companies GDRX Competitors DFIN Competitors PLTK Competitors PINC Competitors UPWK Competitors OLO Competitors XMTR Competitors LZ Competitors PHR Competitors NVEE Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:SY) was last updated on 8/2/2025 by MarketBeat.com Staff From Our PartnersElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | SponsoredChina just unlocked Nvidia’s AI chips—what that means for youTired of Missing Big AI Moves Like Nvidia? You’re not the problem—your trading system is. Tim’s XGPT system...Timothy Sykes | SponsoredThis Social Security Shift Could Boost Benefits by 400%If you currently collect Social Security—or plan to in the future—this may be one of the most important update...InvestorPlace | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredA new rule goes live in July — and the banks are quietly crushing itA little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Stre...American Alternative | SponsoredYour blueprint for crypto wealthMark August 12th on your calendar. 27 of crypto's most successful minds are about to reveal everything…Crypto 101 Media | SponsoredJeff Bezos Launches "ChatGPT Killer"?Amazon just launched Nova—its secretive new AI system designed to rival ChatGPT. Bezos says he now spends 95% ...Stansberry Research | SponsoredAlien rocks potentially worth trillions…It might look like just a weird rock—but it’s tied to a discovery 60 Minutes says could be worth up to $16 tri...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding So-Young International Inc. Sponsored ADR Please log in to your account or sign up in order to add this asset to your watchlist. Share So-Young International With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
